Skip to content

The adolescent in focus: digital treatment using the internet

The adolescent in focus: digital treatment using the internet - The adolescent in focus: digital treatment using the internet

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON31930
Enrollment
80
Registered
2009-01-19
Start date
2009-02-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Sugar

Interventions

The intervention consists of a website to which test-subjects and professional caregivers are given access. The website exists of a personal component and a generic component. Within the personal c

Sponsors

Universitair Medisch Centrum Sint Radboud
Lead Sponsor

Eligibility

Age
12 Years to 99 Years

Inclusion criteria

Inclusion criteria: Eligible participants are 13 through 18 years of age at the onset of the study, are diagnosed with Diabetes Mellitus type 1 and are undergoing treatment in the Children's Diabetes Centre Nijmegen (KDCN).

Exclusion criteria

Exclusion criteria: There are no exclusioncriteria. There are no known conditions in the population that are foreseen to influence treatmenteffects, leaving all members of the population of the KDCN entitled to participation in the study.

Design outcomes

Secondary

MeasureTime frame
Naast primaire uitkomstmaten zal de invloed van het project op de kwaliteit van leven worden onderzocht. Hiervoor wordt gebruik gemaakt van de Nederlandse vertaling van de diabetesmodule van de Pediatric Quality of Life voor adolescenten (PedsQL Diabetes Module Version 3.0 - teen report, ages 13 - 18; Varni, 2003). Varni, J.W., Burwinnkle, T.M., Jacobs, J.R., Gottschalk, M., Kaufman, F., Jones, K.L. (2003). The PedsQLin Type 1 and Type 2 Diabetes Reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Type 1 Diabetes Module, Diabetes Care, 3, 631 - 637.

Primary

MeasureTime frame
Results will be primarily aimed at improvement of communication among caregivers and between adolescent and caregivers. This improvement in communication and fine-tuning of care will be tested by means of: - adolescents* and parents* satisfaction with the provided care. Measurement of this variable will be conducted using a yet to be developed questionnaire. The outcome of a stakeholdersanalysis, to be held in April 2008, will be applied as the basis for development of the questionnaire. - the number of non-planned visits of the adolescent to the clinic and the number of phone calls made by the adolescent to a caregiver. These measures are so-called hard digits; frequencies are being considered as numerics. - the adolescents* confidence in diabetes self management. This variable is measured by using the Dutch translation of the Diabetes Self care Questionnaire (VDZ; van der Ven, 2003). Considering the expectations revolving the variables and results from recent research we expect the intervention to positively affect the adolescents* adherence. Adherence will be measured using: - the degree of control over behavior that is considered necessary for adequate diabetes self care. This variable will be measured using a yet to be developed questionnaire. - the relationship between advised and observed frequency of monitoring blood glucose values. The relationship will be measured using the mutual proportion. - the degree of increased (experienced) knowledge about diabetes and diabetes control. For measurement of diabetes knowledge the *Diabetes Knowledge Test* will be used (DKT; Fitzgerald, 1998). The questionnaire will be translated into Dutch and validated as such, possibly in association with the University of Gent, Belgium. - HbA1c values. These values are hard digits and this variable will be considered a numeric variable. Fitzgerald, J. T., Funnell, M. M., Hess, G. E., Barr, P. A., Anderson, R. M., Hiss, R. G., Davis, W. K. (1998). The r

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)